- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04465110
Effects of Chronic Dietary Grape Seed Extract Supplementation on Aortic Stiffness and Hemodynamic Responses to Exercise in Obese Males
July 9, 2020 updated by: California Baptist University
Effects of Chronic Dietary Grape Seed Extract Supplementation on Aortic Stiffness and Hemodynamic Responses in Obese/Overweight Males During Submaximal Exercise
It was demonstrated that acute dietary supplementation with GSE reduced arterial blood pressure via reduction in Q in obese individuals.
However, no studies have investigated the chronic effects of dietary GSE supplementation on hemodynamic responses during exercise.
Given the fact that obesity is associated with an impaired function of eNOS, the effect of chronic dietary GSE supplementation on abnormal blood pressure response to exercise and aortic stiffness (AoS) needs be elucidated.
Thus, it is hypothesized that GSE decreases systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), Q, and aortic stiffness at rest and during exercise.
This study would determine that this supplementation may be used as a non-pharmacological intervention to prevent incident hypertension and cardiovascular events during exercise via enhanced endothelial function.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
We investigated whether elevated blood pressure and aortic stiffness (AoS) characterized in obese and overweight males (N=10) are reduced following chronic GSE supplementation during exercise.
Systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate (HR), stroke volume (SV), cardiac output (Q), total vascular conductance (TVC), and AoS to two submaximal cycling exercises (40% and 60% VO2peak) were compared 7 days after ingestion of GSE or placebo (PL) within an one week washout period.
Compared with PL, GSE supplementation significantly decreased MAP at rest, 40%, and 60% workloads.
AoS was significantly reduced at rest.
Q tended to be decreased, but there was no significant difference.
GSE had no effect on HR, TVC, and SV.
Our study indicates that chronic supplementation with GSE reduces arterial pressure at rest and during exercise primarily via the combined reduction of AoS and Q.
Thus, GSE can be a dietary supplement to treat augmented blood pressure responses in obese and overweight males at rest and during exercise.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Riverside, California, United States, 92504
- California Baptist University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 29 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Overweight: 25-29.9 kg/m2
- Obese: > 30 kg/m2
- Waist circumference: > 90 cm
Exclusion Criteria:
- Antihypertensive medication
- Major systemic disease (cancer)
- Musculoskeletal diseases
- Cardiovascular diseases or symptoms including chest pain
- Myocardial infarction
- Arrhythmias
- Heart failure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: GSE group
Subjects took a single dose of 600 mg GSE in capsule form through ingestion 7 days
|
Subjects took a single dose of 600 mg GSE in capsule form through ingestion 2 hours prior to testing Dietary Supplement: Grape seed extract Two capsule grape seed extract (total 600 mg) per day
|
|
PLACEBO_COMPARATOR: Placebo group
Subjects took a single dose of 600 mg starch in capsule form through ingestion 7 days
|
Subjects took a single dose of 600 mg GSE in capsule form through ingestion 2 hours prior to testing Dietary Supplement: Grape seed extract Two capsule grape seed extract (total 600 mg) per day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in heart rate at rest and during exercise
Time Frame: 7 day supplementation
|
beats per minute
|
7 day supplementation
|
|
change in stroke volume at rest and during exercise
Time Frame: 7 day supplementation
|
volume per stroke
|
7 day supplementation
|
|
change in cardiac output at rest and during exercise
Time Frame: 7 day supplementation
|
total volume for one minute
|
7 day supplementation
|
|
change in systolic blood pressure at rest and during exercise
Time Frame: 7 day supplementation
|
pressure exerted during contraction
|
7 day supplementation
|
|
change in diastolic blood pressure at rest and during exercise
Time Frame: 7 day supplementation
|
pressure exerted during relaxation
|
7 day supplementation
|
|
change in total vascular conductance at rest and during exercise
Time Frame: 7 day supplementation
|
one reported value (cardiac output/mean arterial pressure)
|
7 day supplementation
|
|
change in aortic stiffness at rest
Time Frame: 7 day supplementation
|
Arbitrary unit
|
7 day supplementation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2019
Primary Completion (ACTUAL)
April 22, 2020
Study Completion (ACTUAL)
April 22, 2020
Study Registration Dates
First Submitted
July 6, 2020
First Submitted That Met QC Criteria
July 6, 2020
First Posted (ACTUAL)
July 9, 2020
Study Record Updates
Last Update Posted (ACTUAL)
July 13, 2020
Last Update Submitted That Met QC Criteria
July 9, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 109-1819-EXP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
To determine the chronic effects of dietary grape seed extraction, all data collected at rest and during exercise will be shared with other researchers in the publication
IPD Sharing Time Frame
All data will be available after publication
IPD Sharing Access Criteria
People can access the data based on the copyright of a journal after its publication.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity Adult Onset
-
University of North Carolina, Chapel HillMetagenics, Inc.; North Carolina Translational and Clinical Sciences InstituteCompleted
-
Universitas DiponegoroCompletedObesity Adult OnsetIndonesia
-
Recep Tayyip Erdogan UniversityCompletedObesity | Obesity Adult Onset | Obesity; EndocrineTurkey
-
University of MinhoHospital de Braga; Universidade do Porto; Fundação para a Ciência e a Tecnologia and other collaboratorsActive, not recruitingEating Behavior | Obesity Adult OnsetPortugal
-
Celia BañulsInstituto de Salud Carlos IIICompleted
-
Kecioren Education and Training HospitalCompletedDifficult Airway Intubation | Obesity Adult OnsetTurkey
-
Ruijin HospitalRecruitingStill's Disease, Adult-OnsetChina
-
Fondation IldysLille Catholic UniversityCompleted
-
R-Pharm International, LLCData Management 365; Federal State Budgetary Educational Institution for Higher... and other collaboratorsWithdrawnAdult-Onset Still's Disease | AOSDRussian Federation
-
Charite University, Berlin, GermanyTerminatedAdult-Onset Still´s DiseaseGermany
Clinical Trials on Grape Seed Extract
-
Clinical Nutrition Research Center, Illinois Institute...Polyphenolics, Inc.CompletedHypertensionUnited States
-
University of ParmaAzienda Ospedaliero-Universitaria di ParmaSuspendedDiet ModificationItaly
-
California Baptist UniversityCompleted
-
Shahid Beheshti University of Medical SciencesTabriz UniversityCompletedHyperlipidemiaIran, Islamic Republic of
-
Marwa SalemUnknownRetention & Fracture of Emax Laminate Veneers
-
California Baptist UniversityCompletedDietary SupplementationUnited States
-
California Baptist UniversityCompletedDietary SupplementationUnited States
-
Liaquat University of Medical & Health SciencesCompletedHypertension | Elevated Blood PressurePakistan
-
Applied Science & Performance InstituteCompletedCognitive Change | Mood Change | Mental ProcessesUnited States
-
Cairo UniversityCompleted